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Abstract 
 
Neurodevelopmental disorders (NDDs) are highly prevalent and severely debilitating brain 
illnesses caused by aberrant brain growth and development. Resulting in cognitive, social, motor, 
language and affective disabilities, common NDDs include autism spectrum disorder (ASD), 
intellectual disability, communication/speech disorders, motor/tic disorders and attention deficit 
hyperactivity disorder. Affecting neurogenesis, glia/neuronal proliferation and migration, synapse 
formation and myelination, aberrant neural development occurs over a substantial period of time. 
Genetic, epigenetic, and environmental factors play a key role in NDD pathogenesis. Animal models 
are an indispensable tool to study NDDs. Paralleling clinical findings, we comprehensively evaluate 
various preclinical tests and models which target key (social, cognitive, motor) neurobehavioral 
domains of ASD and other common NDDs. Covering both traditional (rodent) and alternative NDD 
models, we outline the emerging areas of research and emphasize how preclinical models play a key 
role in gaining translational and mechanistic insights into NDDs and their therapy. 
 
Keywords: neurodevelopmental disorder, model organism, experimental model, preclinical study, 
translational research 
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Research highlights: 
 
 Neurodevelopmental disorders are common and widespread psychiatric illnesses 
 Autism and other neurodevelopmental deficits often occur in early development 
 Animal models are a valuable tool to study autism and other neurodevelopmental disorders 
 We parallel clinical and preclinical data to gain a translational perspective of these illnesses 
 
 
5 
 
1. Introduction 
Neurodevelopmental disorders (NDDs) represent clinically heterogeneous, heritable 
psychiatric illnesses caused by aberrant brain growth and development (American Psychiatric et al., 
2013; Hansen et al., 2013; Homberg et al., 2015). Presenting with motor, cognitive, language and 
affective disabilities, common NDDs include autism spectrum disorder (ASD), social communication 
disorders, intellectual disability (ID), attention deficit hyperactivity (ADHD) and motor/tic disorders 
(Table 1, Fig. 1) (American Psychiatric et al., 2013; Hansen et al., 2013). While NDD symptoms 
typically emerge during childhood, aberrant neural development usually starts during early 
embryogenesis (Hu et al., 2014; Sadler, 2006) and continues over a substantial period of time. 
Affecting neurogenesis, glia/neuronal proliferation and migration, synapse formation and myelination 
(Fig. 1) (Ding, 2015; Frederick and Stanwood, 2009; Hu et al., 2014; Rice and Barone, 2000), these 
developmental changes lead to long-lasting behavioral and physiological deficits in both child- and 
adulthood (Bergner et al., 2010; Buckley et al., 2009; Krishnan, 2005). Depending on the brain 
structure(s) or the stage of neural development affected, clinical manifestations of NDDs range from 
specific symptoms to global mental impairments (Table 1) (American Psychiatric et al., 2013; Hansen 
et al., 2013). In addition, NDDs frequently co-occur (e.g., ADHD with learning disability, ASD with 
ID) and overlap with other brain disorders, forming a complex spectrum of neuropsychiatric 
comorbidities (Fig. 1) (Bergner et al., 2010; Buckley et al., 2009; Krishnan, 2005) 
NDDs remain a relatively unmet biomedical concern (Bergner et al., 2010; Buckley et al., 
2009; Krishnan, 2005) with high prevalence and socio-economic impact (Dykens, 2015). In addition, 
NDDs cause significant distress and persistent impairments of behavior, memory/learning, social 
communication, occupational performance and other important daily activities (American Psychiatric 
et al., 2013; Hansen et al., 2013). Multiple therapeutic approaches to NDDs include pharmacotherapy, 
behavioral therapy and rehabilitation, such as physical or speech/language therapy (Hansen et al., 
2013). However, specific and effective treatments for NDDs are lacking, as we do not know the 
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biological targets and the exact symptoms, which are also often detected at clinically advanced stages, 
past the best therapeutic intervention period (Homberg et al., 2015). This, as well as the growing 
health burden of NDDs (Fig. 2), necessitate further translational research in this field and the 
development of valid preclinical models, novel biomarkers and therapies.  
To address these challenges, the International Stress and Behavior Society (ISBS) has 
established the Strategic Task Force on NDDs - a team of international experts representing different 
clinical and preclinical fields (Homberg et al., 2015). Complementing the Panel’s recommendations 
on improving pharmacotherapy of NDDs (Homberg et al., 2015), the present review parallels clinical 
symptoms of ASD and several other common NDDs with their existing preclinical paradigms, and 
evaluates various tests and models of animal neurobehavioral development, social behaviors, 
restricted interests and behavioral perseverations. Covering both traditional (rodent) and alternative 
models of NDDs, we outline the emerging areas of research and emphasize how preclinical models 
help gain translational and mechanistic insights into NDDs and their therapy. 
2. Animals models of neurodevelopmental disorders 
Since a key function of the nervous system is to produce behavior, behavioral analyses 
provide the most meaningful assessment of the central nervous system (CNS) and its deficits. For 
example, rodent tests are commonly used to measure neural phenotypes in behavioral genetics, 
developmental psychobiology, psychopharmacology and neurotoxicology (Buelke-Sam and Kimmel, 
1979; Butcher, 1976; Elmazar and Sullivan, 1981; Reiter, 1978; Vorhees et al., 1979). However, 
because of multiple limitations inherent in experimental modeling of complex human brain disorders 
(Cachat et al., 2011; Kalueff and Tuohimaa, 2005b; Kalueff et al., 2007e), targeting the entire 
spectrum of clinical NDDs is impossible (Table 1). Nevertheless, animal paradigms continue to be 
indispensable for studying the neurobiology of human NDDs (Kalueff et al., 2007e). In general, a 
good animal model should possess three main attributes: construct validity (conforming to the 
underlying rationale of the disease), face validity (mimicking some of the characteristics of the 
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disease) and predictive validity (allowing the prediction of novel disease symptoms, or identification 
of disease treatments) (Kalueff et al., 2007e; Stewart and Kalueff, 2015). The animal model should 
also combine genetic tractability, tools to visualize and manipulate neurons in vivo, and the ability to 
translate findings to patients based upon conserved neurobiology. Two major groups of preclinical 
paradigms merit discussion here. One group is behavioral tests which assess NDD-linked phenotypes, 
and therefore often have high face and predictive validity. The second group represents experimental 
models relevant to NDD pathogenesis (Fig. 2), and therefore possesses high construct validity. Both 
types of preclinical paradigms can be used complementarily to gain translational and mechanistic 
insights into NDD pathogenesis (Table 2). 
2.1. Tests of rodent neurobehavioral development 
Numerous tests for neurobehavioral development in young rodents can be organized into five 
broad behavioral domains: simple reflexes, sensory function, motor function/coordination, 
learning/memory and emotionality (Table 3). Simple reflex tests measure behavioral responses that 
are relatively simple in form, resistant to motivational influences, and often mediated by a small 
number of sensory and motor neurons. The appearance or disappearance of reflexes from birth is used 
to assess the rate of maturation of the CNS and differences in the day of appearance or disappearance 
of reflexes may be used as predictors for NDDs. Tests used to measure sensory development and 
reactivity assess a wide range of different (e.g., visual, vestibular, auditory and olfactory) systems 
(Table 3). Differences or abnormalities in rate of sensory development may be indicative of abnormal 
neuronal pathways associated with NDDs. Furthermore, tests used to assess locomotor activity reflect 
both exploratory behavior and a state of arousal or “nonspecific excitability” in the context of motor 
function (Table 3). Proper development of motor coordination can be assessed using numerous tests, 
such as rotarod and gait analysis, which provide spatial and temporal characteristics of limb 
movement during locomotion. 
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Addressing another critical (cognitive) domain, Table 3 outlines learning and memory tests 
suitable for young rodents, whose immature sensory and motor systems place limitations on their 
ability to perform certain tasks or express certain learned associations. These tests have been used to 
assess such aspects of learning and memory as habituation, avoidance, retention, conditioning, and 
spatial, delayed, discrimination, and reversal learning. Finally, emotionality represents a key 
neurobehavioral domain often affected during neural development in both animal and clinical studies 
(Homberg et al., 2015). In general, assessing emotionality in rodents is a difficult task. Four issues are 
of particular importance to consider: how to measure emotions directly, how to classify emotional 
states, how to attribute overt behavior to covert emotional states, and how to identify animal models 
that are good models of human emotional reactions. Several robust tests of emotionality are 
summarized in Table 3 and have been recently comprehensively evaluated elsewhere (Cryan and 
Holmes, 2005; Griebel and Holmes, 2013), including altered emotionality in several rodent models of 
NDDs (Bolivar and Brown, 1994; Branchi and Ricceri, 2002; Martinez-Cue et al., 2006; Ricceri et 
al., 2007). 
2.2. Rodent tests of social behaviors  
Social deficits are a common symptom of ASD and many other NDDs. Popular rodent 
behavioral assays designed to target social behaviors characterize social interaction and 
communication deficits (Bishop and Lahvis, 2011; Crawley, 2004, 2007; Hunsaker, 2012; Lahvis and 
Black, 2011; Silverman et al., 2010b). Rodents are particularly suitable to model NDD-associated 
social deficits since both mice and rats are highly social species with a wide repertoire of social 
behaviors, including parenting, communal nesting and juvenile play as well as sexual and aggressive 
behaviors as adults. One of the most popular paradigms, the social interaction test evaluates social 
responses of the subject mouse directly facing a co-specific (i.e., a freely moving stimulus mouse). 
Importantly, this also allows a concomitant measurement of ultrasonic vocalizations (USVs) to 
simultaneously assess rodent social and vocal repertoires. During the social interaction test, mice 
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typically investigate each other by sniffing (of anogenital regions, heads or the rest of the body), by 
crawling over/under each other and/or by reciprocal following. This test is easy to perform, and can 
utilize either same-sex or mixed pairs. Moreover, in both the male-female and female-female social 
interaction tests, emission of USVs (40-80 kHz) is a consistent robust phenomenon, considered an 
index of social interest and motivation (Moles et al., 2007; Nyby, 2001; Scattoni et al., 2009). USVs 
positively correlate with social investigation, such as anogenital sniffing (Moles et al., 2007; Nyby, 
1983; Sales, 1972; Scattoni et al., 2011). Digital spectrographic analysis enables the collection of 
further information on USVs (e.g., waveforms of the calls), classified into several categories based on 
internal frequency, duration and spectrographic shape (Ey et al., 2013; Roy et al., 2012; Scattoni et 
al., 2008; Scattoni et al., 2011; Tyzio et al., 2014). Importantly, since mice engage in social 
interaction as juveniles, these tests are suitable for studying developmental trajectories of social 
behaviors, which is relevant to modeling NDDs in general.  
In behavioral studies, mouse preference for a social (vs. non-social) context, as well their 
ability to recognize an unfamiliar co-specific (social recognition), are important traits. The social 
approach task evaluates these two social aspects at two different test phases in the same apparatus 
(Moy et al., 2004; Nadler et al., 2004; Yang et al., 2011). This test has become extremely popular in 
phenotyping of ASD mouse models, since it is unbiased to individual variations in behavior of a 
social stimulus (a stranger mouse confined under small wire cages); is less time-consuming than other 
related tests (Pearson et al., 2012); can be used in an automated manner; and because mice can be 
tested at different ages (an opportunity scarcely exploited so far), thus offering the possibility to 
follow developmental trajectories. However, since the stimulus mouse is contained under a wire cup, 
the three-chamber social approach apparatus only measures social approach initiated by the subject 
mouse (also note that the strain of both stimulus and testing mouse can influence the results, and 
therefore must be carefully considered). This permits the olfactory, auditory and visual contact, 
avoids sexual and aggressive behaviors, but also prevents a fine-grain evaluation of the social 
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behaviors and their reciprocity. As already mentioned, various other disorders, both within (e.g., 
ADHD) and beyond NDD spectrum (e.g., schizophrenia, depression, anxiety), present with social 
deficits, and a careful dissection of these factors in respective animal assays is necessary. Thus, it is 
useful to combine the social approach with the social interaction tests (Feyder et al., 2010; Jamain et 
al., 2008; Peca J et al., 2011; Radyushkin et al., 2009; Schmeisser et al., 2012), as well as to apply 
tests assessing other behavioral domains (e.g., activity, memory, affect), for a more accurate 
characterization of rodent social deficits.  
Since NDDs typically have an early onset, behavioral phenotyping targeting the early 
developmental period is crucial (Bale et al., 2010; Branchi and Ricceri, 2002), although aberrant 
phenotypes can be present at different developmental stages. For instance, USVs, emitted by mouse 
pups in response to separation from mother and littermates, are considered a reliable index of pup 
social motivation (Branchi et al., 2010; Ehret, 2005; Sewell, 1970), suitable for the identification of 
early communication deficits in ASD mouse models (Wohr and Scattoni, 2013). Pup isolation-
induced USVs can reflect aversive affective states, eliciting maternal exploratory and retrieval 
behaviors (Knutson et al., 2002; Panksepp, 2003; Zippelius and Schleidt, 1956). Usually pups 
vocalize for a brief period after separation from the nest, and then rapidly habituate. During early 
postnatal days, USVs follow a clear strain-dependent ontogenetic profile, with a typical peak around 
Days 5-8, and a progressive decrease afterwards (Elwood and Keeling, 1982; Hahn et al., 1998; 
Roubertoux et al., 1996). Unusual calling patterns and reduced vocalization rates, sometimes 
associated with a restricted vocal repertoire (Michetti, 2012), are detected in several genetic mouse 
models of NDDs (Bozdagi et al., 2010; Romano et al., 2013; Scattoni et al., 2008; Schmeisser et al., 
2012; Wohr et al., 2012; Won et al., 2012; Yang et al., 2012). When evaluating development of vocal 
response, it is crucial to consider potential confounders, as altered body temperature, weight and 
growth can affect both quantitative and qualitative UVSs (Bozdagi et al., 2010; Hamilton et al., 2011; 
Romano et al., 2013; Roy et al., 2012; Shair et al., 2003; Veenstra-VanderWeele et al., 2012; Yang et 
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al., 2012). Overall, pup USV characterization permit identification of an ASD-like phenotype at an 
early stage of development, in situations when other social or behavioral phenotypes are difficult to 
obtain. 
2.3. Rodent models of repetitive behavior and motor stereotypies 
One of the symptoms of ASD and some other NDDs is restricted/repetitive patterns of 
behavior, interests or activities, manifested by stereotypic motor movements (i.e., repetitive 
sequences of motor behavior, topographically and morphologically invariant, often rhythmical), 
inflexible adherence to routines, ritualized patterns and circumscribed or perseverative interest 
(American Psychiatric et al., 2013). In general, repetitive behaviors can be divided in two classes, 
roughly indicating ‘lower-order’ (repetition of movements and stereotypies) and ‘higher order’ 
(insistence on sameness, lack of behavioral flexibility, with a distinct cognitive component) responses 
(Lewis et al., 2007). Although rodents exhibit several spontaneous motor stereotypies (e.g., excessive 
vertical jumping, back-flipping, circling, digging, chewing), excessive self-grooming behavior has 
been by far the most well-studied stereotypy in ASD mouse models (Fig. 2), likely because it is a 
common phenotype with a complex ‘patterned’ sequential nature, and is easy to measure in rodents 
(Crawley, 2007; Creese and Iversen, 1975; Kalueff et al., 2007a; Korff and Harvey, 2006; Lewis et 
al., 2007; McFarlane et al., 2008; Moy et al., 2008; Pogorelov et al., 2005; Turner et al., 2001), also 
see Table 2. 
Recapitulating behavioral perseveration, pathological self-grooming in rodents can also be 
valuable for examining neural pathways of NDDs (Pearson et al., 2011; Reynolds et al., 2013; 
Silverman et al., 2010a). For example, ephrins A (ephrin-A ligands), ephrin A receptors (members of 
the receptor protein-tyrosine kinase superfamily) and their genes are strongly implicated in neural 
development (Wurzman et al., 2014). Serving as an important membrane-anchored cellular protein, 
ephrin A modulates neuronal differentiation and synaptic plasticity, and ephrin-A2/A3 receptor 
double knockout mice display repetitive self-grooming, motor retardation and social deficits, 
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recapitulating some clinical symptoms of ASD (Wurzman et al., 2014). Similarly, exaggerated self-
grooming is seen in the inbred BTBR mice, displaying callossal agenesis, social deficits and 
behavioral inflexibility relevant to ASD (Amodeo et al., 2014; Brodkin et al., 2014). Interestingly, 
cholinergic agents which correct some clinical ASD symptoms (Van Schalkwyk et al., 2015) 
predictably reduce self-grooming (Amodeo et al., 2014) and other ASD-like behaviors (Karvat and 
Kimchi, 2014) in BTBR mice, whose self-grooming is also corrected by glutamatergic drugs 
(Silverman et al., 2012; Silverman et al., 2010a). 
Several other candidate ‘NDD’ genes include the SHANK family - SHANK1, SHANK2 and 
SHANK3 (Guilmatre et al., 2014) modulating synaptic function in the brain. In addition to ASD-like 
social deficits and repetitive behaviors, Shank mutant mice display aberrant grooming (Schmeisser, 
2015) including elevated repetitive self-grooming in Shank1+/− and −/− (Sungur et al., 2014), 
Shank2−/− (Schmeisser et al., 2012),(Won et al., 2012) and Shank3−/− mice (Peca et al., 2011; Wang 
et al., 2011; Yang et al., 2012). Ablation of the GABA-synthesizing enzyme glutamic acid 
decarboxylase (Gad67) also results in mouse ASD-like behavior, including increased self-grooming 
and cognitive and social deficits (Zhang et al., 2014).  
Related to grooming phenotypes, barbering (behavior-induced hair loss, Fig. 2), including 
both hetero- and self-barbering, can be used to assess repetitive behaviors (Kalueff et al., 2006). Note, 
however, that stressors and other laboratory environment factors (e.g., poor housing, nutrition/diet, 
lack of enrichment) may often trigger such behaviors in laboratory rodent colonies (Garner et al., 
2011), (Dufour et al., 2010), (Garner et al., 2004), and therefore should be carefully monitored to 
avoid confusion with NDD-related behaviors. Another rodent paradigm widely used in the context of 
repetitive behavior is the marble burying test, which measures repetitive behavior related to digging, 
not correlated with anxiety traits and primarily stimulated by novelty (Thomas et al., 2009). Notably, 
motor repetitive behaviors, such as self-grooming and marble burying, are often more sensitive (than 
social responses) in testing different drugs in NDD mouse models (e.g., mGluR5 antagonists 
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(Silverman et al., 2012; Silverman et al., 2010a) and acetylcholine esterase inhibitors (Amodeo et al., 
2014) in BTBR mice), raising the questions of potential differential sensitivity of various NDD 
phenotypes to drugs.  
2.4. Rodent models of restricted interests and behavioral inflexibility 
Because ASD patients often follow fixed routines and resist changes (Chen et al., 2009; Frith 
et al., 1991; Goldman et al., 2009), such restricted interests and behavioral inflexibility can be 
modeled in rodents by assessing their motivation to explore novel objects and to nose-poke holes in 
the wall or floor (Elsabbagh et al., 2013). Perseverative exploration of only a limited set of (rather 
than all) available objects or holes may resemble restricted interests in ASD humans (Moy et al., 
2008). Thus, it is possible to model this insistence on sameness in mice by assessing their flexibility 
to switch from an established habit to a new habit through reversal learning in the T-maze or Morris 
water maze. Briefly, after establishment of a spatial habit (e.g., reinforcing entries into the left arm of 
a T-maze or locating the hidden escape platform in one quadrant of a Morris water maze), the 
experimental set is changed and the mouse is requested to abandon the previously acquired habit and 
shift to a new location. ASD mouse models displaying repetitive behaviors usually perform well 
during the acquisition phase, but are generally slower in the acquisition of the new information during 
the reversal phase (Bader et al., 2011; Gandal et al., 2012; Guariglia and Chadman, 2013; Karvat and 
Kimchi, 2012; Lee et al., 2013; Moy et al., 2007; Penagarikano et al., 2011; Sala et al., 2013; Sala et 
al., 2011; Wang et al., 2011; Zhao et al., 2010). Other, more complex and refined rodent attentional 
set shifting tasks continue to be developed in mice (Colacicco et al., 2002), (Garner et al., 2006) and 
rats (McAlonan and Brown, 2003) to target cognitive deficits associated ASD, ADHD and other 
NDDs (Tait et al., 2014), (Scheggia et al., 2014). 
2.5. Rodent behavioral tests targeting comorbid traits 
Together with core symptoms, NDD patients often present comorbid traits, including seizures, 
altered emotional and sensory processing, as well as sleep and gastrointestinal deficits (Fassio et al., 
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2011; Gilby and O'Brien, 2013; van Steensel et al., 2011; Woolfenden et al., 2012). However, their 
underlying biological mechanisms remain poorly understood. For example, if comorbid traits are 
integral to the NDD (Argyropoulos et al., 2013), many of them must also be present in valid NDD 
mouse models, and assessed as associated symptoms (Crawley, 2007; Roullet and Crawley, 2011). 
The presence of comorbid phenotypes, such as seizures or altered anxiety levels, may also interfere 
with spontaneous behavioral responses, thus confounding the interpretations of results (Roullet and 
Crawley, 2011). Evaluation of comorbid traits (selected on the basis of the information already 
available on the phenotype or on the basis of the role played by the gene alteration on CNS function) 
is therefore critical for a fine-grain behavioral characterization of NDD mouse models.  
For example, seizures are observed in 8-25% of the ASD population (Hara, 2007; Jeste, 2011; 
Sansa et al., 2011), and are particularly common in ASD patients with ID (Woolfenden et al., 2012). 
The presence of seizures can be evaluated in mice using tonic–clonic rating scales or EEG recordings. 
Seizures can be spontaneous or drug-induced, and once started, interrupt normal activities such as 
walking, exploring, sniffing and grooming (Morrison et al., 1996). The brain activity recordings 
permit the evaluation of the neuronal activity and identify the seizures as a spike-wave pattern 
(Blundell et al., 2009; Chemelli et al., 1999; Zhou et al., 2009). Seizure susceptibility and high levels 
of seizures have been reported in several ASD mouse models, including Shank3B, CNTNAP2, Pten 
and Gabrb3 knockout mice (DeLorey et al., 1998; Peca J et al., 2011; Penagarikano et al., 2011; Zhou 
et al., 2009). In line with this, some epileptic strains, such as Synapsin I (Syn1) and Synapsin II 
(Syn2) knockout mice, show ASD-like traits (Greco et al., 2013), collectively emphasizing the 
overlap between this NDD and epileptic pathogenesis. 
Anxiety is also common in NDD patients (Argyropoulos et al., 2013; Gillott et al., 2001; van 
Steensel et al., 2011), and standardized mouse assays to measure anxiety-like behaviors are primarily 
based on approach-avoidance conflicts since mice are nocturnal and avoid lit open novel 
environments. Currently, the most popular anxiety-related tests include the elevated plus-maze and 
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light-dark tests, recently reviewed in (Cryan and Holmes, 2005; Griebel and Holmes, 2013). The 
elevated plus maze consists of two open and two enclosed arms, and the light-dark test represents a 
two-compartment apparatus with a dark enclosed and an open lit compartments. An unusually high 
preference for ‘protected’ closed arms and for ‘safe’ dark compartment is considered as an excessive 
anxiety-like trait. Interestingly, several ASD mouse models, such as the Nlgn2, 5HTT, FMR1, 
Avpr1b, Shank2, Shank3 and other mice with mutations that may be relevant to autism, show 
increased anxiety profiles, in addition to at least one other core symptoms (Blundell et al., 2009; 
Holmes et al., 2003; Peca J et al., 2011; Schmeisser et al., 2012; Spencer et al., 2005; Wersinger et 
al., 2002; Won et al., 2012). 
Finally, mounting evidence suggests early motor abnormalities in ASD neonates and children 
(Iverson and Braddock, 2013; LeBarton and Iverson, 2013; Phagava et al., 2008) and infants at 
increased risk for ASD (Leonard et al., 2013). Since motor dysfunction can affect other NDD 
symptoms, preclinical studies in mouse models have recently addressed this issue by fine-grain 
characterization of spontaneous motor behavior (De Filippis et al., 2010; Romano et al., 2013). This 
may be important as a behavioral biomarker of NDD at an early stage of development, when other 
behavioral phenotypes are difficult to record. 
2.6. Rodent models relevant to Tourette syndrome 
 A common NDD, Tourette syndrome is a highly heritable, early-onset illness (American 
Psychiatric et al., 2013) characterized by motor and phonic tics - habitual sudden, rapid, recurrent and 
non-rhythmic movements or vocalizations
 
(Yu et al., 2015). Often comorbid with other NDDs such as 
ADHD and ASD, clinical Tourette syndrome frequently overlaps with obsessive-compulsive disorder 
(OCD), anxiety and depression ((APA), 2013; Felling and Singer, 2011). Given excellent recent 
expert reviews of animal models of Tourette syndrome in this journal (Macri et al., 2013b),(Bronfeld 
et al., 2013), (Martino and Laviola, 2013), they will be only briefly mentioned here. Several mouse 
models have recently been proposed as relevant to Tourette syndrome, including DAT-/- mice with 
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elevated dopaminergic tone, overall hyperactivity and stereotyped self-grooming patterns, which 
parallel inflexible behavioral actions in Tourette patients (Berridge et al., 2005; Denys et al., 2013). 
Mutant mice lacking D1A receptors display aberrant behavior including shorter (and more incomplete) 
grooming episodes with disrupted sequential patterns (Cromwell et al., 1998), potentially relevant to 
dopaminergic deficits in Tourette syndrome. Other brain neuromediators, including glutamate, 
serotonin, GABA, norepinephrine (NE) and histamine, play an important role in clinical Tourette’s 
syndrome and its preclinical models (e.g., (Nordstrom et al., 2015), (Macri et al., 2013a), (Rapanelli 
and Pittenger, 2015)). For example, histidine carboxylase is an enzyme producing histamine from 
histidine. In line with clinical data implicating mutations in the human histidine decarboxylase (HDC) 
gene in Tourette syndrome (Castellan Baldan et al., 2014), the Hdc-/- mice recapitulate some aspects 
of this syndrome, including tic-like stereotypic grooming (Xu et al., 2015b). Together with the 
growing number of animal models of Tourette syndrome and other tic disorders (Macri et al., 2013a), 
(Godar et al., 2015), (Xu et al., 2015a), this suggests that future translational research will generate 
significant insights on these NDDs. 
2.7. Selected rodent models of attention deficit and hyperactivity  
Novel insights into the genetics and neurobiology of ADHD have already benefitted from 
animal models, and will be discussed here in the context of NDDs. Perhaps, the most robust and 
easiest ADHD symptom to measure in animal models is motor hyperactivity (hyperlocomotion). The 
control of hyperactivity is crucially linked to dopamine signalling, and both increased (Antrop et al., 
2000; Corkum et al., 2001; Porrino et al., 1983) and decreased dopamine (Giros et al., 1996; 
Viggiano et al., 2002) can lead to hyperactivity in animal models. Other measurements of ADHD-like 
behavior, including inattention and increased impulsivity, are more difficult to model (see further), 
suggesting that most animal paradigms represent “ADHD-like” rather than complete “ADHD” 
models (Sontag et al., 2010). For example, the spontaneous hypertensive rat (SHR) created by 
selectively inbreeding rats of the Wistar-Kyoto (WKY) strain (Okamoto and Aoki, 1963) shows face 
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validity for some aspects of ADHD, including hyperactivity in a novel environment, excessive 
responses during a fixed interval/extinction schedule and difficulty in operant learning (Mook et al., 
1993; Sagvolden, 2000; Wyss et al., 1992). Paralleling core symptoms of ADHD (hyperactivity, 
impulsivity and inattention), SHR are also less responsive to delayed reinforcement than WKY 
controls. Their behavioral alterations can be rescued by amphetamine (Myers et al., 1982; Sagvolden 
et al., 1992), methylphenidate (MPH) (van den Bergh et al., 2006) and the α2-agonist guanfacine 
(Sagvolden, 2006) providing further links to the human disorder. The SHR also demonstrate construct 
validity for ADHD, as their behavioral phenotypes are likely caused by altered dopamine signalling. 
SHR carry a 160-base pair insertion in intron 2 of the DAT gene Dat/Slc6a3, possibly affecting its 
expression in a manner similar to the VNTR seen in human ADHD patients (Vandenbergh et al., 
1992). SHR have several abnormalities in cathecholaminergic function, including reduced release of 
dopamine in the prefrontal cortex, nucleus accumbens and striatum, decreased dopamine turnover in 
the substantia nigra, ventral tegmentum and frontal cortex (Russell, 2002) and elevated 
norepinephrine in several brain areas (De Villiers et al., 1995). Nevertheless, despite its excellent 
attributes, the SHR is not the best ADHD model. For example, the background WKY rat strain is less 
active (than other rats) and does not perform well on some tasks (van den Bergh et al., 2006) making 
the behavioral alterations in SHR seem more pronounced. The high blood pressure (hypertension) 
seen in SHR is not observed in ADHD and could explain some of the behavioral alterations, 
including changes to learning and memory (Davids et al., 2003). In order to address this issue, a non-
hypertensive WKHA strain has been generated by back-crossing SHR rats to the WKY strain. 
However, while WKHA rats are hyperactive, they do not respond to MPH treatment, suggesting that 
they may not have predictive validity for ADHD (Hendley and Ohlsson, 1991). In general, despite its 
limitations, the SHR fulfils many of the criteria needed in an ADHD-like animal model, suggesting 
that further study may bring even more insights into the etiology of the disease.  
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Polymorphisms in the DAT gene have been linked to susceptibility for ADHD in a number of 
clinical studies. The Dat knockout (Dat-/-) mice show a spectrum of ADHD-like phenotypes 
including hyperactivity in a novel environment, a reduction of startle response and an impairment of 
learning and memory (Giros et al., 1996; Sora et al., 1998; Zhuang et al., 2001) (also see details of 
heterozygous Dat+/- mouse phenotypes in (Kalueff et al., 2007c)). The behavioral symptoms of Dat-
/- mice can be rescued by both amphetamine and MPH (Gainetdinov et al., 1998). Nevertheless, 
although DAT is linked to ADHD clinically, Dat knockout mice may not represent a good ADHD-
like model due to an extreme phenotype, such as a 5-fold increase in dopamine levels in the striatum 
of these mice coupled to compensatory changes in other dopaminergic signalling pathways. There is 
also increased activity of tyrosine hydroxylase (Jaber et al., 1999) and down-regulated expression of 
postsynaptic dopamine D1 and D2 receptors (Gainetdinov et al., 1998). This phenotype is at odds 
with the presumed pathology of clinical ADHD (which suggests reduced dopamine in the prefrontal 
cortex) and the postulated therapeutic action of many anti-ADHD drugs (including MPH and 
amphetamine) via DAT. Although the behavioral phenotype of Dat knockout mice can also be 
rescued by SSRIs, non-selective serotonin agonists and 5-HT2A antagonists (Barr et al., 2004), SSRIs 
are not particularly effective in controlling major disordered symptoms of ADHD clinically. Finally, 
due to their highly hyperactive phenotype, memory and learning testing is almost impossible to 
perform in Dat-/- mice, which also show unwanted growth retardation and an increased likelihood of 
premature death (Gainetdinov et al., 1998; Giros et al., 1996). Notably, Dat knock-down mice, which 
only have 10% of normal Dat function, also show hyperactivity, anti-hyperkinetic responses to 
amphetamine, excessive grooming and tendency to persevere in walking in straight lines (Berridge et 
al., 2005).  
The coloboma mouse has a radiation-induced mutation in the SNAP25 gene resulting in a 50% 
reduction of SNAP25-mediated synaptic transmission. Heterozygous coloboma mutant mice (Cm+/-) 
show spontaneous hyperactivity reduced by amphetamine but not MPH (Hess et al., 1996). Coloboma 
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mutants also display impulsivity and impaired inhibition in a delayed reinforcement task, being 
unable to wait as long as controls for a larger reward (Bruno et al., 2007). Mutation of SNAP25 
reduces dopamine in the dorsal striatum, increases cortical dopamine and striatal and accumbal 
norepinephrine (Jones et al., 2001; Raber et al., 1997). Thus, an interaction between these two 
monoamines’ signalling mechanisms seems to be important in coloboma mutants. These mice also 
seem to have predictive validity for ADHD, since identification of their SNAP25 mutation led to 
candidate gene studies that eventually revealed an association between the gene and human ADHD 
(Brophy et al., 2002). As a caveat, however, Cm+/- also have visual problems, while homozygous 
animals die early in pregnancy, these phenotypes are not associated with ADHD.  
Finally, as an example of a developmental toxin that can lead to the symptoms of ADHD, rats 
lesioned with 6-hydroxydopamine (6-OHDA) on postnatal day 1 show hyperactivity and reduced 
learning at certain developmental period. 6-OHDA is a neurotoxin that is uptaken by the DAT and 
NE transporter, and selectively kills both types of neurons. Motor and learning defects of 6-OHDA 
rats can be rescued by applying amphetamine or MPH. The hyperactivity of 6-OHDA-lesioned 
animals is accompanied by reduced dopamine in the striatum, prefrontal cortex, midbrain and 
amygdala, and increased striatal serotonin (Luthman et al., 1989). However, the noradrenergic system 
does not appear to be altered in these animals. Notably, the behavioral phenotype of 6-OHDA rats 
normalizes by adulthood, demonstrating the ability of the dopaminergic system to recover from some 
lesions during early development (Davids et al., 2003).  
2.8. Developing translational models of NDDs using non-rodent species 
While rodents are an indispensable tool for NDD research (Homberg et al., 2015), other 
model organisms are gaining popularity in this field. For example, invertebrate models, such as fruit 
flies (Drosophila melanogaster), have traditionally been used in developmental and behavioral 
genetics, and while out of scope here, are be mentioned for their emerging potential in modeling 
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NDDs, including ASD and ADHD (see (Kaur et al., 2015; van der Voet et al., 2015; Wise et al., 
2015) for details).  
Mounting evidence suggests zebrafish (Danio rerio) as a valuable translational model 
(Kalueff et al., 2014a; Stewart et al., 2014a) for behavioral analysis in both larval and adult fish and 
in-depth characterization of their rich behavioural repertoire (Kalueff et al., 2013; Kalueff et al., 
2014b; Stewart et al., 2015a; Stewart et al., 2015d). The large number of mutant strains, as well as the 
availability of modern genetic, optogenetic and neuroimaging tools (Kalueff et al., 2014a; Kalueff et 
al., 2014b; Stewart et al., 2015d; Ullmann et al., 2015; Ullmann et al., 2010), make zebrafish an 
excellent model for studying NDDs. For instance, zebrafish have recently been suggested as a 
promising model of ASD (Stewart et al., 2014b), especially as fish spent >80% of their time 
swimming together in shoals (Fig. 2D) and display robust kin recognition and social preference 
phenotypes (Kalueff et al., 2013). Similar to rodent models, zebrafish also display robust social 
preference, which can be easily tested in aquatic versions of social interaction and social preference 
paradigms discussed above for rodents (Fig. 2). Additionally, multiple pharmacological, genetic and 
environmental manipulations can disrupt zebrafish shoaling behavior (Stewart et al., 2014b). The 
ability to swim in a stereotypic manner (e.g., corner-to-corner, as after treatment with nicotine, or in 
tight circles, as after treatment with glutamatergic antagonists ketamine, MK-801 or phencyclidine 
(Stewart et al., 2015b)), raises the possibility of using zebrafish as models of repetitive behaviors, 
relevant to motor symptoms of ASD and other NDDs.  
Despite the numerous advantages of zebrafish for developmental neuroscience, there are 
currently very few ADHD-related models in zebrafish. Hyperactivity is arguably the easiest ADHD-
related phenotype to assess in zebrafish, presenting as increased distance travelled, velocity and 
movement frequency/duration in both adult (Blaser et al., 2009; Lopez-Patino et al., 2008) and larval 
fish (Chen et al., 2011; Norton, 2011; Saili et al., 2012; Seibt et al., 2010). Even fewer studies 
targeted impulsivity and inattention in zebrafish, most likely reflecting challenges of designing 
21 
 
specific tests (Parker et al., 2012) and the general under-appreciation of zebrafish as a behavioral 
model of NDDs. Several successes, however, indicate the growing potential of zebrafish models of 
ADHD. For example, morpholino-mediated inhibition of nr4a2, an ADHD-linked dopaminergic 
orphan nuclear receptor (Saili et al., 2012), during development leads to permanent hyperactivity 
(Blin et al., 2008). A recently developed 5-choice serial reaction time task (5CSRTT) can measure 
impulsivity in zebrafish similar to rodents (Parker et al., 2014b; Parker et al., 2014c; Parker et al., 
2012). To analyze the role of ADHD-linked genes in zebrafish phenotypes, the latrophilin 3.1 
(lphn3.1) gene has been comprehensively evaluated during zebrafish development (Lange et al., 
2012b). LPHN3 is an orphan adhesion-G protein-coupled receptor whose gene contains a variation 
that conveys a risk haplotype for ADHD (Arcos-Burgos et al., 2010). latrophilin3.1 represents a 
zebrafish homolog of human LPHN3, expressed in the brain up to 6 dpf. The reduction of its function 
during zebrafish development by injecting morpholinos results in hyperactive phenotype of the 
morphants, also displaying more bursts of acceleration (increased motor impulsivity) – the two 
ADHD-like phenotypes rescued by anti-ADHD drugs MPH and atomoxetine (Lange et al., 2012b) 
(Fig. 2). Together with some other recent interesting genetic models (e.g., (Huang et al., 2015)), this 
illustrates the growing utility of zebrafish in modelling ADHD and other NDDs.  
Chick models are also gaining popularity in neurodevelopmental research, especially since 
they display robust social, motor and cognitive phenotypes relevant to clinical NNDs (Fig. 2E) and 
demonstrate critical disease ‘susceptibility’ windows during the neural development (Koshiba et al., 
2013a; Mimura et al., 2013; Mimura, 2013). For example, chicks display high preference for social 
groups (like rodents), and emit social vocalizations (e.g., ‘alarm’ and ‘joy’ calls when isolated or 
meeting peers, respectively (Koshiba et al., 2013c)). Social environment is particularly important for 
chicken normal behaviors and their overall sensitivity to environmental stressors (Koshiba et al., 
2013a; Mimura et al., 2013; Mimura, 2013). For example, deficit of peer rearing affects 
monoaminergic systems in young chicks, evoking depressive-like behaviors (Koshiba, 2013; 
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Shirakawa, 2013b) and suppressing forebrain growth around critical susceptible age (Koshiba et al., 
2013a).  
Non-human primate models, such as those based on common marmoset (Callithrix jacchus), 
represent another promising area of NDD research (Fig. 2E). Marmosets display rich vocal 
communication with approximately 10 types of ‘calls’, likely representing (based on contexts) 
positive or negative emotional states (Koshiba et al., 2011; Koshiba et al., 2013b). Together with 
parallel assessment of vocalizations and behaviors, the socio-behavioral trajectories in marmosets 
have recently been studied using multivariate repression. For example, such analyses revealed 
important time windows around weaning, critical for establishing normal social and motor behaviors, 
also showing pathological hyperactivity in marmosets if reared without adequate social environment 
(Koshiba et al., 2013b). Light-induced disruption of the young marmoset circadian rhythm affects 
their adult behaviors, leading to more ‘hyperactive’ patterns of social and motor activity (Koshiba et 
al., 2015b; Senoo et al., 2011) (also see the link between marmoset emotional responses, body 
temperature (Karino, 2015; Koshiba, 2013; Shirakawa, 2013a) and hormones (Koshiba et al., 2011), 
Fig. 2E).  
3. Selected emerging translational questions 
A complex, systems biology-based approach that parallels clinical studies, preclinical animal 
models, biomarker discovery and mechanistically-driven in-vitro research is becoming increasingly 
critical for improving our understanding of brain disorders and their therapies (Cryan and Slattery, 
2007; Kalueff and Stewart, 2015; Kalueff et al., 2015; Kalueff et al., 2007d; Redei et al., 2001; 
Stewart and Kalueff, 2015). As outlined here, marked progress in studying NDDs has been achieved 
through translational analyses using preclinical (animal) models and tests (Table 1) (Homberg et al., 
2015). However, more work is needed in order to fully understand the pathobiology of NDDs. For 
example, while the opportunity of targeted genetic manipulations in mice resulted in significant 
advances in our understanding of genetics and biology of NDDs, the availability of genetically altered 
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rat models (especially due to the development of modern gene-editing approaches, such CRISPR-
Cas9 or Zinc-Finger Nuclease (ZFN) technologies) may significantly further the progress in the field 
(Kaneko and Mashimo, 2015), (Parker et al., 2014a). Beyond their obvious advantage of larger size, 
rats have a wider range of well established complex behavioral paradigms (compared to mice), 
particularly critical to evaluate fine behaviors, cognitive function and emotionality, critical for NDD 
research (Parker et al., 2014a). The Panel recognizes the importance of genetically modified rats in 
studying a wide spectrum of NDDs and other brain disorders (Kalueff et al., 2010). Several 
additional, emerging challenges can be relevant to building translational bridges in this field. Thus, 
while we may not be able to provide definite answers to these questions at present, their discussion 
can benefit future studies of NDDs. 
3.1. Making research more translational: from lab to bedside 
Discussion of translational NDD models would be incomplete without mentioning clinical 
studies utilizing behavioral approaches and biomarkers similar to those developed for rodents, 
zebrafish, chicks and non-human primates (see above). One interesting example of such translational 
bridge is “reverse translation”, or "bedside to bench", experiment performed in patients with 
psychiatric disorders (schizophrenia and bipolar disorder) by analysing their behavioural pattern of 
activity and directly comparing them with the behavioral pattern of mutant mice (e.g., hyperactive 
DAT knockouts) recorded in similar conditions (Perry et al., 2009), (Perry et al., 2010). Such 
translational angle is also important given the need to develop ‘early’ and ‘very early’ behavioral and 
physiological biomarkers of clinical NDDs. For instance, multivariate analyses of neurological 
development across age in normal infants vs. infants with aberrant neural development shows 
correlation of physiological biomarkers (blood and brain imaging data) with specific behavioral 
phenotypes, such as head control and rolling behavior (Fig. 2F) (Koshiba et al., 2015a). This raises 
the possibility of using such phenotypes as potential ‘early’ behavioral biomarkers of NDDs (Koshiba 
et al., 2015a), crucial in the absence of other, more complex behaviors to aid diagnostics. This is 
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particularly important because early neural development represents a critical window for maximizing 
the success of therapeutic intervention. Finally, the development of video-tracking and other 
behavior-recording methods (e.g., those utilizing smart phones (Mimura et al., 2015)) to study older 
children and adults further fosters NDD research and extraction of novel behavioural biomarkers (Fig. 
2F). 
3.2. Moving from single- to poly-phenotype models 
As already mentioned, the majority of NDDs are multi-factorial brain illnesses with many 
genetic and environmental determinants. Therefore, a conceptual approach deconstructing these 
disorders into simpler and easily quantifiable phenotypic units (‘endophenotypes’) is a reasonable 
strategy (Gottesman and Gould, 2003; Gould and Gottesman, 2006; Lenzenweger, 2013). The 
endophenotype concept has been successful in dissecting various brain disorders, their overlapping 
and unique symptoms, as well as candidate biomarkers and genes across the disorder spectrum 
(Courtet et al., 2011; Crossley et al., 2014; Ikeda et al., 2013; Ivleva et al., 2010); also see (Kalueff et 
al., 2008b; Kalueff and Stewart, 2015; Kalueff et al., 2015; LaPorte et al., 2010; Stewart and Kalueff, 
2015) for detailed discussion. Recognizing that multiple phenotypes can be shared by several distinct 
disorders, such strategy is in line with the recently suggested research domain criteria, RDOCs 
(Casey et al., 2013; Cuthbert and Insel, 2010; Insel et al., 2010; Insel, 2014) that target phenotypic 
dimensions, rather than categories, of psychiatric diagnoses (Gottesman and McGue, in press; Kalueff 
et al., 2015). However, in parsing individual endophenotypes across and within the disorders in both 
clinical and preclinical models, the predominant focus of biological psychiatry continues to be narrow 
and phenotype-centered (Ditzen et al., 2012; Filiou et al., 2011; Gormanns et al., 2011; Kalueff et al., 
2008b; Maccarrone et al., 2013). From a conceptual standpoint, if a CNS disorder consists of several 
distinct endophenotypes A, B and C, then focusing on clinical and preclinical models or tests that 
target more than one endophenotype (e.g., A and B or A, B and C) is better than using experimental 
models or clinical studies that assess only one. Using ASD as an example, an animal model is likely 
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more valid if it assesses both social deficits and behavior perseverations, as compared to a model with 
only one aberrant phenotype. A growing number of studies are already embracing this approach, 
monitoring several distinct endophenotypes of a disorder and discovering their biomarkers and 
potential treatments (Amodeo et al., 2014; Burket et al., 2013; Kalueff et al., 2015; Pearson et al., 
2011; Reynolds et al., 2013; Silverman et al., 2010a) (Fig. 4). The main challenge, however, is that it 
may be insufficient to dissect ‘unique’ molecular mechanisms of endophenotypes A, B and C from 
their ‘shared’ pathways (e.g., A+B or B+C) because, as suggested recently (Kalueff et al., 2014c; 
Kalueff et al., 2015), principally novel genetic and molecular ‘cross-talk’ pathways may underlie the 
pathogenetic coupling of such endophenotypes (e.g., ‘A<->B’ or ‘B<->C’) without affecting each 
endophenotype per se (Fig. 4). Remaining to yet be established, the putative mechanisms by which 
such novel classes of genes act, may include synchronizing or synergizing several distinct disordered 
processes (Stewart et al., 2015c). Applying this concept to NDDs, it is possible that in clinical or 
experimental ASD, social deficits can be pathogenetically linked to repetitive behaviors via cross-talk 
molecular mechanisms. Likewise, in addition to its hallmark symptoms - hyperactivity and attention 
deficit – ADHD may rely on additional molecular networks integrating the two endophenotypes 
together, thus making it the single well-defined clinical disorder. Complementing current theories of 
NDDs, the pathological linkage between several distinct disordered endophenotypes, in addition to 
focusing on them separately or in combination, merit further scrutiny (Fig. 4). For example, this can 
be achieved by applying a network-based ‘cloud’ approach to modeling NDDs, where individual 
endophenotypes (as well as biomarkers and disorders) are not only assessed in clinical and preclinical 
studies individually or in combinations, but are assessed by novel linkages between them (Fig. 4). 
Based on this rationale, clinical cases with two synchronized phenotypes (e.g., repetitive behaviors 
and social deficits in ASD) may demonstrate a stronger (and, therefore, more debilitating or 
treatment-resistant) NDD, compared to cases when core endophenotypes are expressed in less 
organized manner (Fig 4, therefore, implying their weaker pathogenetic integration and less 
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pronounced overall pathogenesis). Clearly, this necessitates further integrative clinical studies and 
respective innovative preclinical models of NDD pathogenesis. 
3.3. Monoamines as neurotrophic factors: lessons from serotonin 
While brain neurotransmitters play a key role in NDDs, it is often overlooked that in early 
development they also act as neurotrophic factors (Homberg et al., 2010). As one illustrative 
example, consider the serotonergic system – a target of many pharmaceutical agents (e.g., 
antidepressants and antipsychotics) used to treat NDDs, with multiple genetic polymorphisms 
conferring the risks for NDDs (Lesch and Waider, 2012). Although the precise role of serotonin in 
NDDs is not fully understood, it mediates aversive processing (Deakin and Graeff, 1991), behavioral 
inhibition (Cools et al., 2008) and social behavior (Kiser et al., 2012), which are often affected in 
NDDs. The common underlying function of serotonin may be the modulation of sensitivity to 
environmental stimuli (Homberg, 2012), a role mostly ascribed to serotonin acting as a 
neurotransmitter. However, serotonin also acts as an important neurotrophic factor during early 
development (Gaspar et al., 2003), and may shape brain circuits involved in these processes. The 
latter function is likely to be critical for NDDs.  
Serotonin is first generated in the developing brain at mid-gestation, by serotonergic neurons 
in the raphe nuclei of the brainstem, mediated by the neuronal isoform tryptophan hydroxylase 2 
(TPH2) (Gaspar et al., 2003). Serotonin is synthesized from the essential amino acid tryptophan and 
packed into vesicles by vesicular monoamine transporter (VMAT), whereas SERT is responsible for 
the reuptake of serotonin into the presynaptic nerve terminal, and thereby determines synaptic 
serotonin levels (Kriegebaum et al., 2010). During development, circulating serotonin of 
gastrointestinal, placental and maternal origins produced by peripheral isoform TpH1 penetrate into 
the developing brain (Bonnin and Levitt, 2011). There it influences developmental processes, 
including cell division, differentiation and migration (Gaspar et al., 2003). These developmental 
processes may also involve non-serotonergic neurons, since SERT is transiently expressed in non-
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serotonergic cells in the brain during development (Homberg et al., 2010). Indeed, SERT is expressed 
in specific sets of glutamatergic neurons in the thalamus and in thalamocortical projection neurons, as 
well as in prefrontal cortex and hippocampus, and takes up extrasynaptic serotonin during perinatal 
CNS development, until approximately P14 (corresponding to the third trimester of human 
pregnancy) (Gaspar et al., 2003). This serotonin is expected to be derived from serotonin-producing 
raphe neurons traveling a long distance in the developing brain (Kullyev et al., 2010). The role of 
SERT in glutamatergic thalamocortical neurons is particularly well established, as SERT regulates 
sensory map architecture (Chen et al., 2015). For example, knockout of SERT in these neurons causes 
lasting alterations in thalamocortical axon patterning, spatial organizations of cortical neurons and 
dendritic arborization in sensory cortex (Gaspar et al., 2003). These developmental effects of 
serotonin are specific for non-serotonergic neurons, since SERT knockdown in serotonin-producing 
neurons does not impair barrel maps (Chen et al., 2015). Likewise, excessive serotonin levels in 
SERT knockout rats is associated with disrupted topographic patterning of both the barrel and visual 
cortex (Cases et al., 1996; Miceli et al., 2013; Murphy and Lesch, 2008; Persico et al., 2001). In 
addition, the outgrowth of raphe neurons to the prefrontal cortex and cortical layering are altered in 
SERT knockout rodents (Altamura et al., 2007; Witteveen et al., 2013). Behaviorally, SERT 
knockout is consistently associated with anxiety-like behavior (Kalueff et al., 2010) and impaired 
social interactions (Kiser et al., 2012), symptoms that are key to NDDs. In contrast, behavioral 
inhibition is reduced in rodents lacking SERT (Holmes et al., 2002; Homberg et al., 2007a). Thus, 
there is strong but indirect evidence that serotonergic genetic variance modulates neurodevelopmental 
processes involved in the pathogenesis of NDDs. In rodents, administration of SSRIs during 
pregnancy and during the first 2 postnatal weeks reduces social play in rats and alters sensory 
processing, cortical wiring and myelin sheet formation (Simpson et al., 2011; Xu et al., 2004). These 
findings resemble those associated with ASD (Deoni et al., 2015; Zikopoulos and Barbas, 2010) and 
SERT in rodents (Homberg et al., 2007b). SSRI exposure decreases cortical dendritic arbor 
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complexity prenatally (Chameau et al., 2009; Smit-Rigter et al., 2012) while during P2-P11 it 
decreases dendritic complexity in the prefrontal cortex and evokes anxiety-like behavior (Rebello et 
al., 2014) (similar to SERT knockout rodents (Kalueff et al., 2010)). Thus, further research is needed 
to examine both the neurotransmitter and neurotrophic roles of serotonin and other brain 
neuromediators in NDD pathogenesis. 
3.4. Understanding gene-environment correlations and environmental enrichment  
Another problem to address in future translational studies is the potentially self-perpetuating 
nature of NDDs (Fig. 2B). For example, since aberrant neural development often results in 
debilitating NDD behavioral symptoms (e.g., social, cognitive or motor deficits) from early 
childhood, this disrupts normal social and affective interactions of an affected individual with their 
social environment (Fig. 2C). Accordingly, this can increase risks of the environment becoming more 
adverse for affected individuals. Because healthy social/environmental stimulation is important for 
shaping neural plasticity in maturing brain and for developing efficient behavioral adaptations from 
early age, the evoked social/environmental adversity may further impair neural development, 
worsening the existing NDD by creating a pathogenetic ‘vicious circle’ (Fig. 2). The recognition that 
the individual’s exposure to the environment can be a function of their genotype, called Gene-
Environment correlations (Jaffee and Price, 2007), is relatively recent in biological psychiatry. 
Conceptually, it complements the widely accepted notion of Gene x Environment interactions (GxE), 
which reflect how genotypes modify the sensitivity to environmental factors (Duncan et al., 2014; 
Kalueff et al., 2007d; Le Strat et al., 2009). Highly relevant to NDD pathogenesis, the Gene-
Environment correlations (Fig. 2C) may have multiple clinical implications. For example, correcting 
behavioral strategies (e.g., pharmacologically or behaviorally) in ASD or ID children can improve 
their interaction with social environment at a ‘critical’ early age. Moreover, educating parents and 
peers on how to best deal with special needs patients can improve their integration into the society, 
therefore reducing ‘early’ environmental adversity. Collectively, this may not only improve clinical 
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symptoms of the existing NDD, but, in parallel, prevent the risks of additional (e.g., stress/adversity-
triggered) neurodevelopmental deficits (Fig. 2C). From a practical standpoint, a potential strategy to 
target Gene-Environment correlations in experimental models of NDDs can involve correlational 
analyses of social components displayed by multiple individuals in social interactions. Improvement 
of software tools to analyze social interactions of multiple animals in detail (e.g., assessing social 
components sequentially with a high time- and space- resolution) may significantly empower the 
assessment of Gene-Environment correlations in biological experiments. As the concept of Gene-
Environment correlations is gaining more recognition in neuropsychiatry (Jaffee and Price, 2007), 
the development of their experimental preclinical models may represent an important and novel 
strategic direction of NDD research (Homberg et al., 2015).   
Paralleling clinical data on positive effects of cognitive and behavioral therapy in various 
NDDs (e.g., (Morand-Beaulieu et al., 2015), (Boyer et al., 2015)), the ability of early environmental 
interventions to reverse or rescue aberrant phenotypes in animal models of NDDs is particularly 
interesting (Nithianantharajah and Hannan, 2006). For example, Fmr1-knockout mice, a model of 
FXS, display hyperactivity and a lack of habituation that is rescued in animals raised in an enriched 
environment (Restivo et al., 2005). In mice deficient for Mecp2, a genetic model of Rett syndrome, 
early environmental enrichment rescued memory deficits, motor coordination and anxiety-like 
behaviors in a sex-specific manner (Lonetti et al., 2010), whereas environmental enrichment reversed 
the increase in repetitive self-grooming behavior in BTBR mice (Reynolds et al., 2013). Taken 
together, these preclinical studies further support the need to investigate a possible role for 
environmental treatments in alleviating the symptoms of NDDs. 
4. Conclusion 
In summary, while NDDs are triggered by aberrant neural development, their pathogenesis 
involves a complex interplay between developmental, genetic, endocrine, immune and neural 
abnormalities. The extensive research covered here illustrates the existing challenges in identifying 
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the neurobiological basis as well as clarifying susceptibility, resilience and strategies for novel 
effective treatments of NDDs.  
As already emphasized, both traditional ‘rodent’ mouse and rat models (extensively used in 
NDD research) are also increasingly complemented by the growing spectrum of alternative model 
organisms, including zebrafish, chicks and non-human primates. Overall, experimental animal 
models are critical to increase our understanding of NDDs, including studying behavior, neuronal 
morphology and gene expression patterns across developmental stages before and during the 
manifestation of disorders-related symptoms (Homberg et al., 2015). In addition, preclinical models 
permit the functional assessment of the impact of genes and gene networks at the level of genetic, 
synaptic and neuronal networks of cognition, behavior and neural systems. Paralleling clinical 
findings, such models begin to play a more critical role in gaining translational and mechanistic 
insights into NDD pathogenesis. 
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Figure 1. The spectrum nature of neurodevelopmental disorders (NDDs). Panel A presents the 
spectrum of neurodevelopmental and other associated disorders. Panel B shows phenotypic domain 
structure and heritability of common NDDs (red – reduced, green – increased; also see Table 1). ASD 
– autism spectrum disorder, ID – intellectual disabilities, ADHD – attention deficit hyperactivity 
disorder, OCD – obsessive compulsive disorder, PTSD – post-traumatic stress disorder. Panel C 
summarizes the temporal dynamics of key neuronal processes related to neural development. Panel D 
illustrates typical onset of selected common neurodevelopmental disorders. 
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Figure 2. The growing clinical and preclinical importance of neurodevelopmental disorders 
(NDDs). Panel A demonstrates global prevalence of NDDs and their costs (USA, $B per year; Center 
for Disease Control/CDC, 2014). Panel B shows rapid growths in occurrence of NDDs, such as ASD 
and ADHD, in the last decade (ASD data represent prevalence in 8 year olds (2015) and ADHD data 
represent prevalence in children 3-17 years old (Bloom et al., 2013)). Panel C shows the relative 
‘health burden’ of NDDs and other common human disorders, calculated as year-patients since the 
disorders’ onset and based on average life expectancy of 80 years (AD – Alzheimer’s disease, PD – 
Parkinson’s disease). Note that NDDs are among the most impactful disorders. Inset: the rapidly 
expanding biomedical research on NDDs in the last 20 years, based on Pubmed article search for 
‘neurodevelopmental’ (December 2015). Panel D shows popular model organisms used in 
translational research on NDDs, and relevance of rodent and zebrafish behaviors to various 
phenotypic domains of these disorders. Rodent models of NDDs have been extensively discussed in 
the text. Note overt social, locomotor and repetitive (e.g., grooming, hetero- and self-barbering 
(Kalueff et al., 2007a; Kalueff et al., 2006)) behaviors in rodents. Illustrating the value of zebrafish 
models for NDDs, the bottom left section shows normal and aberrant ASD-like zebrafish shoaling 
behaviors (Stewart et al., 2014b). Botom right section illustrates an ADHD-related zebrafish model 
based on morphants with rediced fucntion of lphn3.1 gene encoding latrophilin 3 (note overall 
baseline hyperactivity associated with impulsive-like acceleation bursts, accompanied by reduced and 
mislaced dopaminergic neurons in the ventral diencephalon) (Lange et al., 2012a, c). Panel E 
illustrates social and cognitive behavioral tests used in preclinical NDD models based on domestic 
chicks (Koshiba et al., 2013a; Koshiba et al., 2013c; Koshiba, 2013; Mimura et al., 2013; Mimura, 
2013; Shirakawa, 2013b) and common marmosets (Karino, 2015; Koshiba et al., 2011; Koshiba et al., 
2015b; Koshiba et al., 2013b; Senoo et al., 2011; Shirakawa, 2013a). Paralleling human clinical 
studies in preterm infants and juveniles (Koshiba et al., 2015a; Koshiba et al., 2013b; Koshiba, 2013) 
, such models can also enhance biomarker discovery. For example, the posterior-lateral forebrain 
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serotonin metabolite, 5-hydroxyindolacetic acid (5HIAA), correlates with chick freezing behavior 
(Koshiba, 2013; Shirakawa, 2013a), whereas emotional phenotypes in common marmosets correlate 
with venous blood progesterone in female adult common marmosets (Koshiba et al., 2011). Panel F 
illustrates several examples of clinical models of NDDs based on behavioral analyses (similar to 
those developed for non-human model organisms), including studying head control and body rolling 
in normal and neurologically affected infants or using computer games in older children (top row) 
(Koshiba et al., 2013b) and behavioral video-tracking of social and locomotor activity in normal vs. 
autistic 2-year old children (bottom row), image courtesy of Noldus IT (Netherlands). 
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Figure 3. The concepts of Gene x Environment interactions (GxE) and Gene-Environment 
correlations (G-E), as well as their potential implications for NDDs and their experimental 
animal models. 
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Figure 4. The proposed ‘integrative’ strategy for modeling of neurodevelopmental disorders 
(NDDs). NDDs usually consist of several ‘core’ symptoms (endophenotypes, e.g., A and B). Panel A 
shows ‘early’ experimental models of brain disorders that focus on targeting individual 
endophenotypes A or B, and more recent complex models examining several endophenotype and 
their respective biomarkers in parallel (A+B vs. A vs. B). As an example here, we use the mouse 
autism-like behaviors (endophenotype A – behavioral perseverations/self-grooming, endophenotype 
B – social deficit). In addition, we suggest that a network-like ‘cloud’ approach must be used to link 
disordered endophenotypes between themselves (i.e., A<->B vs. A+B vs. A vs. B), in order to 
identify their “interplay” genes and biomarkers, in addition to those ‘unique’ and ‘shared’ between 
them. For example, a disorder with stronger synchronization of endophenotypes A and B is likely to 
be more severe and treatment-resistant, as compared to a disease with similar ‘amplitude’ of 
endophenotypes, but the lack of their correlation. Panel B illustrates the importance of tracking the 
activity of all proposed genetic networks across ontogenesis, as different subgroups of genes (A-
specific, B-specific, and ‘interplay’ A<->B genes may show distinct pattern of gene 
activity/expression (Y-axis) during neural development (X-axis). Circles represent the severity of 
phenotype expression (note that subtypes of severe NDDs may include cases of mild but tightly 
coordinated disordered endophenotypes, as well as strongly affected but relatively moderately 
coordinated/overlapping endophenotypes). 
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Table 1. Neurodevelopmental disorders currently listed in Diagnostic Statistical Manual (DSM-
5) (American Psychiatric et al., 2013), also see Table 2 
 
Disorders and their main symptoms Availability of 
animal models 
Intellectual Disabilities (ID) – impairment of mental functions in conceptual (language, reading, 
writing, mathematics, memory, insight, knowledge, interpretation), social (empathy, compassion, 
social judgment, communication and interaction skills, amicability, harmony) and practical 
(personal care, school and/or occupational responsibilities and organization, financial management, 
entertainment, hobby) aspects, including: Intellectual Disability (Intellectual Developmental 
Disorder), Global Developmental Delay, Unspecified Intellectual Disability (Intellectual 
Developmental Disorder)  
+ 
Communication Disorders (CD) – difficulties in language, speech, phonetic fluency or social 
communication, including: Language Disorder, Speech Sound Disorder, Childhood-Onset Fluency 
Disorder (Stuttering), Social (Pragmatic) Communication Disorder, Unspecified Communication 
Disorder  
Not feasible 
Autism Spectrum Disorder (ASD) - persistent reciprocal social deficits (communication and 
interaction), and restricted, repetitive patterns of behavior, interests or thoughts 
+ 
Attention-Deficit/Hyperactivity Disorder (ADHD) - a pattern of inattention and/or hyperactivity-
impulsivity, including: ADHD, Other Specified and Unspecified ADHD 
+ 
 
Specific Learning Disorder - difficulties learning skills like reading, writing, spelling, mathematic 
calculations, etc. 
Not feasible 
Motor Disorders (MD) – impairments of execution of coordinated motor skills, or repetitive 
motor behaviors, including: Developmental Coordination Disorder, Stereotypic Movement 
Disorder  
+ 
 
Tic Disorders (TD) - habitual motor movements or vocalizations which are sudden, rapid, 
recurrent and non-rhythmic, including: Tourette’s Disorder, Persistent (Chronic) Motor or Vocal 
Tic Disorder, Provisional Tic Disorder, Other Specified and Unspecified Tic Disorders 
+ 
 Other Neurodevelopmental Disorders  ? 
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Table 2. Selected animal (rodent) models of neurodevelopmental disorders, abbreviations as in 
Table 1 (also see Fig. 2 and Table 3) (Homberg et al., 2015).  
 
Animal (rodent) model Ease to 
perform 
Throug
hput 
Affected 
domain/phenotype 
Clinical relevance 
Social interaction test ++ + Social deficit*/** Social deficit in ASD 
Social preference test ++ + Social deficit* Social deficit in ASD 
Social recognition + + Social deficit* Social deficit in ASD, ID 
Open field test +++ +++ Hyperlocomotion* Hyperactivity in ADHD 
Homecage observation ++ + Hyperlocomotion* Hyperactivity in ADHD 
Various memory tests ++ + Cognitive deficits* Cognitive deficits in ID and ADHD 
Various attention tests + + Attention deficits Attention deficits in ADHD 
Various impulsivity tests + + Increased impulsivity Increased impulsivity in ADHD 
Self-grooming test +++ +++ Increased grooming  Behavioral perseverations in ASD, TD 
Hetero-grooming ++ + Aberrant grooming Social deficits in ASD, ID 
Self-barbering test  ++ + Hair-loss (barbering) Behavioral perseverations in ASD, TD 
Hetero-barbering ++ + Hair-loss (barbering) Social deficits in ASD, ID 
Open field test +++ +++ Increased stereotypies* Behavioral perseverations in ASD 
Aggression test ++ + Increased aggression** Aggression in ID, ADHD 
Marble burying test +++ +++ Increased burying Behavioral perseverations in ASD 
Homecage observation ++ + Increased stereotypies*  Behavioral perseverations in ASD 
Startle test +++ +++ Aberrant startle* Altered cognition in ADHD and ID 
Ultrasonic vocalizations + ++ Aberrant vocalization Social deficits in ASD, ID or CD 
 
* denotes the availability of similar tests in alternative model organisms, such as zebrafish (Fig. 2) 
** also see shoaling test and mirror biting test in zebrafish (Green et al., 2012; Miller et al., 2013) (Fig. 2D) 
  
42 
 
Table 3. Tests used to measure the neural development and behavior of young rodents 
(Homberg et al., 2015).   
Tests System measured Age of testing Referen-ces 
Simple Reflexes     
Pupillary constriction Sensorimotor PND12 to 
appearance 
(Crofton, 1992) 
Salivation  Sensorimotor PND2 to 
appearance 
(Crofton, 1992) 
Lacrimation Sensorimotor PND2 to 
appearance 
(Crofton, 1992) 
Acoustic startle Auditory, Motor PND6 to 
appearance 
(Fox, 1965) 
Forelimb grasp reflex Somatic, Motor PND2 to 
appearance 
(Blaney et al., 2013; Fox, 1965) 
Hindlimb grasp reflex Somatic, Motor PND2 to 
appearance 
(Amendola et al., 2004; Blaney et al., 
2013; Fox, 1965) 
Loss of crossed-
extensor reflex 
Somatic, Motor PND2 to 
disappearance 
(Blaney et al., 2013; Fox, 1965) 
Loss of rooting 
response 
Somatic, Motor PND2 to 
disappearance 
(Fox, 1965; Roubertoux et al., 1987) 
Vibrissae response Somatic, Motor PND2 to 
appearance 
(Amendola et al., 2004; Blaney et al., 
2013; Fox, 1965) 
Sensory and motor    
Reflex modification Visual, Auditory, 
Olfactory, Somatic 
PND 14-onwards (Wecker et al., 1985) 
Cliff avoidance Visual: depth 
perception  
PND 14-onwards (Fox, 1965) 
Visual placing test Visual, motor 
coordination 
PND14-onwards (Pinto and Enroth-Cugell, 2000) 
Olfactory 
discrimination 
Olfaction  After weaning (Brown and Willner, 1983)  
Swimming test Vestibular, 
Neuromotor 
coordination 
After weaning (Kalueff et al., 2004) 
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Negative geotaxis Vestibular, 
Neuromotor 
coordination 
PND2-onwards (Blaney et al., 2013; Fox, 1965) 
Surface righting  Vestibular, 
Neuromotor 
coordination 
PND 2-onwards (Amendola et al., 2004; Fox, 1965) 
Mid-air righting Vestibular, 
Neuromotor 
coordination 
PND2-onwards (Fox, 1965) 
Hindlimb splay Vestibular, 
Neuromotor 
coordination 
PND2-onwards (Broxup et al., 1989; Moser et al., 1988)  
Gait analysis Neuromotor 
coordination 
After weaning (Wooley et al., 2005) 
Rotarod, accelerod Neuromotor 
coordination 
After weaning (Van Raamsdonk et al., 2005) 
Horizontal rod test Vestibular, 
Neuromotor 
coordination 
After weaning (Kalueff et al., 2008a) 
Forelimb grip strength 
test 
Neuromotor 
coordination, 
muscle strength 
PND2-onwards (Blaney et al., 2013) 
Nest building test Neuromotor 
coordination 
After weaning (Kalueff et al., 2007b) 
Rope climbing test Neuromotor 
coordination, 
muscle strength 
After weaning (Kalueff et al., 2007b) 
Vertical screen test Neuromotor 
coordination, 
muscle strength 
After weaning (Kalueff et al., 2004) 
Self-grooming test Neuromotor 
coordination, 
muscle strength 
After weaning (Kalueff and Tuohimaa, 2004a, 2005a) 
Open Field Locomotor activity PND12-onwards (Alleva et al., 1985; Blaney et al., 2013) 
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Cognitive tests    
Olfactory 
conditioning 
Learning and 
memory 
PND6 onwards  (Sullivan and Wilson, 1995) 
Neonatal T-maze Learning and 
memory 
PND9-onwards (Nagy et al., 1976) 
Hebb Williams Maze Learning and 
memory 
After weaning (Hebb and Williams, 1946; Pritchett and 
Mulder, 2004) 
Morris water maze Learning and 
memory 
After weaning (Morris, 1984) 
Passive avoidance test Learning and 
memory 
After weaning (Cuomo et al., 1996) 
Active avoidance test Learning and 
memory 
After weaning (McNamara et al., 1977) 
Operant conditioning 
schedules 
Learning and 
memory 
After weaning (Cuomo et al., 1996) 
Homing test Learning and 
memory 
PND14-onwards (Alleva et al., 1985; Fox, 1965) 
Object recognition 
test 
Learning and 
memory 
PND22-onwards (Blaney et al., 2013) 
Social/ Emotional    
Ultrasonic 
vocalization 
Anxiety, sociability PND2-onwards (Bolivar and Brown, 1994; Scattoni et 
al., 2009) 
Elevated plus maze Anxiety After weaning (Cuomo et al., 1996) 
Black and white 
transition test 
Anxiety After weaning (Crawley, 1981) 
Social interaction test Anxiety, sociability After weaning (Crawley, 1981) 
Self-grooming 
analysis 
Anxiety, repetitive 
behavior 
After weaning (Kalueff et al., 2007a; Kalueff and 
Tuohimaa, 2004b) 
Suok test Anxiety, 
motorisensory 
integration 
After weaning (Kalueff et al., 2008a; Kalueff and 
Tuohimaa, 2005b) 
Social preference test Sociability After weaning (Ricceri et al., 2007; Silverman and 
Crawley, 2014) 
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